Elite Pharmaceuticals ELTP Balance Sheet (2009-2026)

OTC ELTP
$0.35 +0.03 (+10.63%)
As of: Nov 16, 2026 · 12:14 PM EST
Reported Financials

Elite Pharmaceuticals Quarterly Balance Sheet

Periods 71 quarters
Latest Sep 2026

Elite Pharmaceuticals reported total assets of $144.29M and total liabilities of $22.12M for the quarter ended Sep 2026, up 23.1% year over year. This balance sheet covers 71 quarters of results from Mar 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Mar2009 Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
7.29M8.54M19.78M18.56M17.91M8.24M9.49M9.08M6.24M7.54M8.85M10.00M8.74M11.77M22.20M27.08M21.56M30.27M39.42M35.34M
Cash & Current Investments
7.29M8.54M19.78M18.56M17.91M8.24M9.49M9.08M6.24M7.54M8.85M10.00M8.74M11.77M22.20M27.08M21.56M30.27M39.42M35.34M
Receivables - NetNet Receivables
2.66M3.06M3.97M4.23M5.55M3.09M6.20M10.50M16.01M19.45M20.49M21.44M18.45M29.21M36.22M40.87M48.53M59.72M50.44M63.22M
Receivables - OtherOther Receivables
Receivables
2.66M3.06M3.97M4.23M5.55M3.09M6.20M10.50M16.01M19.45M20.49M21.44M18.45M29.21M36.22M40.87M48.53M59.72M50.44M63.22M
Raw Materials
6.11M5.38M6.95M8.17M5.41M3.27M7.21M7.53M6.66M7.31M7.75M10.15M10.00M11.47M10.56M15.22M12.60M14.11M11.81M
Work In Process
966.001.20M0.10M0.10M1.79M0.09M1.36M1.25M1.80M2.26M1.79M2.70M1.42M2.00M2.26M3.65M3.27M2.13M0.89M
Finished Goods
0.58M0.16M0.43M0.33M2.35M7.81M6.65M5.54M4.47M4.26M4.62M7.31M4.82M5.89M5.34M6.23M5.39M7.96M9.81M
Inventory
6.69M6.74M7.62M7.47M8.60M9.55M11.17M15.22M14.33M12.93M13.83M14.16M20.16M16.24M19.36M18.16M25.10M21.26M24.20M22.52M
Current Deferred Tax AssetsCurrent Deferred Tax
Prepaid Assets
0.83M0.53M0.51M0.22M1.11M1.03M1.00M0.36M1.01M0.52M0.44M0.13M1.14M0.98M0.55M0.14M2.07M1.33M0.91M0.14M
Current Assets
17.48M18.86M31.87M30.47M33.16M21.51M27.44M34.73M37.16M40.01M43.16M45.29M48.05M57.74M77.86M85.79M96.79M112.11M114.49M120.74M
Non-Current Assets
Buildings
Property, Plant & Equipment (Net)PP&E (Net)
5.99M5.95M5.75M10.54M10.23M10.43M10.10M9.77M10.10M10.18M10.57M10.18M9.86M10.33M10.27M10.10M10.04M10.18M10.74M11.20M
Long-Term Investments
Goodwill
Intangibles
6.63M6.63M6.63M6.63M6.63M6.34M6.34M6.34M6.34M6.34M7.24M7.24M7.24M5.64M5.64M5.64M5.64M4.79M4.79M4.79M
Goodwill & Intangibles
6.63M6.63M6.63M6.63M6.63M6.34M6.34M6.34M6.34M6.34M7.24M7.24M7.24M5.64M5.64M5.64M5.64M4.79M4.79M4.79M
Long-Term Deferred Tax
2.17M2.17M2.17M2.17M2.17M2.17M19.43M20.23M22.16M22.14M20.84M20.69M18.37M13.48M11.80M10.33M7.82M6.50M4.64M
Other Non-Current Assets
0.77M0.50M0.70M0.50M0.41M0.43M0.44M0.44M0.44M0.53M0.53M0.54M0.91M0.55M0.55M0.61M0.56M0.56M0.57M0.57M
Non-Current Assets
14.47M16.29M16.24M19.87M19.55M19.39M19.05M35.99M37.54M43.64M44.69M42.90M42.71M38.65M33.48M31.45M29.62M26.18M25.18M23.55M
Assets
31.95M35.15M48.11M50.34M52.72M40.90M46.50M70.72M74.70M83.65M87.85M88.20M90.76M96.39M111.34M117.25M126.41M138.29M139.67M144.29M
Liabilities
Current Liabilities
Accounts Payables
1.28M1.43M1.61M1.72M1.47M2.45M1.87M3.61M2.89M2.71M2.61M1.98M5.84M2.96M5.09M3.42M6.52M6.05M5.59M3.10M
Notes Payables
4.00M4.00M4.00M4.00M4.00M4.00M4.00M4.00M
Dividends payables
Payables
1.28M1.43M1.61M1.72M1.47M2.45M5.87M7.61M6.89M6.71M6.61M5.98M9.84M6.96M5.09M3.42M6.52M6.05M5.59M3.10M
Accumulated Expenses
4.03M4.69M4.81M4.58M4.68M5.05M5.93M11.16M11.88M5.30M6.23M5.70M3.72M3.80M4.58M6.15M5.55M10.19M6.43M6.27M
Other Accumulated Expenses
3.63M3.88M4.00M4.13M4.47M6.41M6.93M0.58M0.32M0.32M0.32M0.29M0.61M0.39M0.40M0.62M0.49M0.73M
Short term Debt
0.40M0.35M0.12M0.50M0.47M0.31M0.25M0.30M0.31M0.30M0.43M0.37M0.29M0.25M0.23M0.23M0.23M0.23M0.23M0.24M
Current Leases
0.04M0.31M0.32M0.36M0.37M0.36M0.37M0.36M0.37M0.38M0.39M0.40M
Current Taxes
0.41M0.05M0.05M0.41M0.56M0.49M0.70M0.42M0.51M0.34M0.75M0.27M0.80M0.59M1.06M0.50M
Current Deferred Revenue
0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.00M
Total Current Liabilities
5.88M6.69M7.08M6.84M6.65M7.83M12.08M19.08M19.16M13.05M14.01M12.85M14.69M11.84M10.76M10.67M13.19M17.39M30.44M18.15M
Non-Current Liabilities
Capital Leases
0.20M1.48M1.40M1.42M1.33M1.25M1.15M1.06M0.96M0.85M0.75M0.64M
Non-Current Debt
1.14M1.14M12.40M14.51M14.82M2.53M2.55M2.45M2.41M2.37M2.33M2.30M2.27M2.25M2.22M2.20M2.18M2.15M2.13M2.11M
Convertible Debt
Non-Current Deferred Revenue
0.04M0.03M0.03M0.03M0.02M0.02M0.02M0.01M0.01M0.01M0.00M
Preferred Stock Liabilities
Operating Leases
0.93M0.84M0.78M0.00M0.02M0.01M0.01M0.00M0.03M1.96M1.85M1.74M1.68M1.55M1.42M1.29M1.16M1.02M0.87M0.72M
Other Non-Current Liabilities
0.88M0.94M1.44M0.75M0.38M0.52M0.71M3.18M5.60M6.30M9.08M21.84M33.57M25.20M47.31M39.79M27.97M17.34M17.25M7.58M
Total Non-Current Liabilities
3.28M3.23M15.50M16.31M15.89M4.10M4.30M6.55M9.12M13.02M15.58M28.08M39.62M31.03M52.89M44.99M32.91M22.02M4.40M3.97M
Total Liabilities
9.16M9.93M22.58M23.15M22.54M11.94M16.38M25.62M28.28M26.07M29.60M40.93M54.31M42.87M63.66M55.66M46.10M39.41M34.84M22.12M
Shareholder's Equity
Total Debt
1.54M1.49M12.51M15.01M15.30M2.84M6.80M6.75M6.71M6.66M6.76M6.66M6.56M6.49M2.45M2.43M2.40M2.38M2.36M2.35M
Common Equity
22.79M25.22M25.53M27.19M30.17M28.96M30.12M45.09M46.41M57.58M58.25M47.27M36.45M53.52M47.68M61.58M80.31M98.88M104.83M122.17M
Liabilities and Shareholders Equity
31.95M35.15M48.11M50.34M52.72M40.90M46.50M70.72M74.70M83.65M87.85M88.20M90.76M96.39M111.34M117.25M126.41M138.29M139.67M144.29M
Treasury Stock
0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M0.31M
Retained Earnings
-142.49M-140.06M-139.75M-138.24M-135.27M-136.50M-135.36M-120.42M-119.72M-116.39M-115.77M-126.81M-137.70M-120.70M-126.59M-112.89M-94.29M-75.83M-69.92M-52.60M
Preferred Shares
Treasury Shares
0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M

Elite Pharmaceuticals Balance Sheet API

Pull Elite Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ELTP&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY